Markets-and-Money
McKesson's $2.25 Billion Acquisition: A Game Changer for Precision Medicine
McKesson's acquisition of Precision Medicine Group for $2.25 billion could reshape the landscape of specialty medicine.
James McAllister • August 25, 2026
US Politics
US-Canada Trade Talks Collapse: What It Means for Cross-Border Investors
The failure of US-Canada trade talks raises stakes for investors in both countries.
Marcus Rivera • Aug 25
Energy
Hennessy Capital's Merger with ONE Nuclear: A New Chapter in Clean Energy
Hennessy Capital Investment Corp. VII's merger with ONE Nuclear could reshape the small modular reactor landscape, signa…
Sarah Chen • Aug 25
Markets-and-Money
McKesson's $2.25 Billion Acquisition: Implications for Healthcare Investors
McKesson's acquisition of Precision Medicine Group for $2.25 billion signals a pivotal shift in healthcare investing.
James McAllister • Aug 25
Free Newsletter
Informed positions start with informed mornings.
Market-moving analysis and institutional-grade research, complimentary and delivered daily.
More Stories
Tech
nVent Electric's $1.75B Maverick Power Bet: Positioning for the AI Infrastructure Boom
Marcus Rivera • Aug 24, 2026
Markets-and-Money
Activist Pressure Builds: Ancora's Strategic Acquisition Move on H.B. Fuller
Sarah Chen • Aug 24, 2026
US Politics
Trump's Tariff Announcement: Implications for the Canadian Auto Industry
James McAllister • Aug 24, 2026
Markets-and-Money
UPS's $2 Billion Investment: Strategic Moves in Healthcare and Supply Chain Logistics
Marcus Rivera • Aug 24, 2026
Energy
nVent Electric's $1.75 Billion Acquisition: A Game Changer in Energy Infrastructure
Sarah Chen • Aug 24, 2026
Markets-and-Money
US-Canada Trade Talks Breakdown: Implications for USD/CAD and Canadian Markets
James McAllister • Aug 24, 2026